Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
AERI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
23.83%20.941.7%$162.94m
VRXValeant Pharmaceuticals International, Inc.
1.85%27.0114.1%$158.93m
BHCBausch Health Cos., Inc.
1.85%27.010.0%$119.66m
GWPHGW Pharmaceuticals Plc
-3.38%109.406.2%$81.05m
MDCOThe Medicines Co.
-3.58%53.3920.2%$78.63m
JAZZJazz Pharmaceuticals Plc
1.11%132.332.3%$69.12m
SAGESAGE Therapeutics, Inc.
-1.93%141.558.6%$52.41m
PRGOPerrigo Co. Plc
-1.67%48.286.8%$46.00m
ENDPEndo International Plc
0.61%4.148.8%$44.46m
HZNPHorizon Therapeutics Plc
0.73%30.236.6%$40.27m
UTHRUnited Therapeutics Corp.
-1.53%89.5714.3%$39.81m
ICPTIntercept Pharmaceuticals, Inc.
1.29%83.0216.9%$39.56m
ICLRICON plc
0.73%147.244.1%$37.50m
CTLTCatalent, Inc.
-0.74%49.482.4%$32.17m
AERIAerie Pharmaceuticals, Inc.
-0.89%18.886.8%$26.95m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.